Soichiro Ushio

Pharmacological properties of Salvia officinalis and its components

Methods Used to Evaluate Pain Behaviors in Rodents

Oxaliplatin-induced neurotoxicity is mediated through gap junction channels and hemichannels and can be prevented by octanol

Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights

Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences

Natural product-based nanoformulations for cancer therapy: Opportunities and challenges

Processed aconite root and its active ingredient neoline may alleviate oxaliplatin-induced peripheral neuropathic pain

Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

The side effects of platinum-based chemotherapy drugs: a review for chemists

An Updated Understanding of the Mechanisms Involved in cHemotherapy-Induced Neuropathy

Neuropathic Pain: From Mechanisms to Treatment

Can Medical Herbs Stimulate Regeneration or Neuroprotection and Treat Neuropathic Pain in Chemotherapy-Induced Peripheral Neuropathy?

Repeated Administration of Amitriptyline Reduces Oxaliplatin-Induced Mechanical Allodynia in Rats

Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents

Involvement of Spinal NR2B-Containing NMDA Receptors in Oxaliplatin-Induced Mechanical Allodynia in Rats

Inhibition of Ca²⁺/Calmodulin-Dependent Protein Kinase II Reverses Oxaliplatin-Induced Mechanical Allodynia in Rats

L Type Ca²⁺ Channel Blockers Prevent Oxaliplatin-Induced Cold Hyperalgesia and TRPM8 Overexpression in Rats